Followers | 680 |
Posts | 141122 |
Boards Moderated | 36 |
Alias Born | 03/10/2004 |
Sunday, March 28, 2021 3:25:34 PM
By: MarketBeat | March 26, 2021
Wall Street brokerages forecast that Crown Castle International Corp. (REIT) (NYSE:CCI) will report sales of $1.50 billion for the current fiscal quarter, Zacks Investment Research reports. Six analysts have made estimates for Crown Castle International's earnings. The highest sales estimate is $1.53 billion and the lowest is $1.47 billion. Crown Castle International posted sales of $1.42 billion during the same quarter last year, which would indicate a positive year-over-year growth rate of 5.6%. The business is expected to issue its next quarterly earnings report on Wednesday, May 5th.
According to Zacks, analysts expect that Crown Castle International will report full-year sales of $6.19 billion for the current year, with estimates ranging from $6.14 billion to $6.25 billion. For the next financial year, analysts expect that the firm will post sales of $6.50 billion, with estimates ranging from $6.44 billion to $6.54 billion. Zacks' sales averages are an average based on a survey of sell-side analysts that follow Crown Castle International.
Crown Castle International (NYSE:CCI) last issued its earnings results on Wednesday, January 27th. The real estate investment trust reported $2.33 earnings per share for the quarter, beating analysts' consensus estimates of $1.58 by $0.75. Crown Castle International had a net margin of 13.09% and a return on equity of 7.57%. The firm had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.51 billion. During the same quarter last year, the business posted $0.43 earnings per share. The company's quarterly revenue was up 4.0% on a year-over-year basis.
Read Full Story »»»
DiscoverGold
Information posted to this board is not meant to suggest any specific action, but to point out the technical signs that can help our readers make their own specific decisions. Caveat emptor!
• DiscoverGold
Recent CCI News
- Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/07/2024 09:28:32 PM
- Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/07/2024 08:01:22 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/07/2024 11:33:38 AM
- Crown Castle’s Highly Qualified Board of Directors is Driving Strategic Actions to Enhance Value • GlobeNewswire Inc. • 05/07/2024 11:30:08 AM
- Boots Capital Sends Letter to Shareholders Highlighting Crown Castle Board's Failures to Deliver Promised Changes While Presiding Over a Decade of Underperformance • PR Newswire (US) • 05/07/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2024 10:00:15 PM
- Form 3/A - Initial statement of beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 05/06/2024 09:56:36 PM
- Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 08:52:50 PM
- Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 08:51:55 PM
- BOOTS CAPITAL ENCOURAGES SHAREHOLDERS TO IGNORE CROWN CASTLE'S DISTRACTING MISREPRESENTATIONS AND JUDGE DIRECTOR CANDIDATES ON THE MERITS • PR Newswire (US) • 05/06/2024 11:30:00 AM
- Crown Castle Files Investor Presentation Highlighting Clear Strategic Plan and Refreshed, Experienced Board to Drive Shareholder Value Creation • GlobeNewswire Inc. • 05/03/2024 11:30:44 AM
- Board Change at Crown Castle is Needed Urgently: Boots Capital Releases Investor Presentation • PR Newswire (US) • 05/01/2024 09:01:00 PM
- Crown Castle Highlights Actions its Board Has Implemented to Successfully Strengthen Foundation and Position Company for Long-Term Value Creation • GlobeNewswire Inc. • 04/25/2024 08:15:15 PM
- BOOTS CAPITAL HIGHLIGHTS CROWN CASTLE'S SIGNIFICANT DESTRUCTION OF SHAREHOLDER VALUE AND FAILED OPERATIONAL STRATEGY DUE TO INEFFECTIVE LEADERSHIP • PR Newswire (US) • 04/22/2024 08:26:00 PM
- Crown Castle Issues Statement Regarding Ted Miller's Latest Attempt to Disrupt the Company's Momentum • GlobeNewswire Inc. • 04/19/2024 08:15:16 PM
- Crown Castle Reports First Quarter 2024 Results and Maintains Outlook for Full Year 2024 • GlobeNewswire Inc. • 04/17/2024 08:15:30 PM
- Delaware Court of Chancery Grants Expedition and Discovery in Hearing on Company's Last-Minute Expansion of Board • PR Newswire (US) • 04/16/2024 01:29:00 PM
- Ted B. Miller Statement on Crown Castle Appointment of Steven J. Moskowitz as President and Chief Executive Officer • PR Newswire (US) • 04/11/2024 03:16:00 PM
- Crown Castle Highlights Actions Underway to Create Stronger and More Valuable Company • GlobeNewswire Inc. • 04/11/2024 11:23:01 AM
- Crown Castle Appoints Tower Industry Veteran Steven J. Moskowitz as President and Chief Executive Officer • GlobeNewswire Inc. • 04/10/2024 08:15:48 PM
- Crown Castle Announces First Quarter 2024 Earnings Conference Call Details • GlobeNewswire Inc. • 04/03/2024 08:15:00 PM
- CROWN CASTLE CO-FOUNDER TED B. MILLER FILES PRELIMINARY PROXY MATERIALS • PR Newswire (US) • 03/28/2024 03:52:00 PM
- Crown Castle Issues Open Letter to Shareholders • GlobeNewswire Inc. • 03/25/2024 11:45:07 AM
- Crown Castle Deserves Better: An Open Letter to Shareholders from Crown Castle Co-Founder Ted B. Miller • PR Newswire (US) • 03/13/2024 10:13:00 PM
- Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/07/2024 10:04:44 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM